GENE ONLINE|News &
Opinion
Blog

2025-11-26|

Study Finds Exercise Intensity Influences Gut Microbiota and Immune System Interaction

by GOAI
Share To

A recent study has examined the relationship between exercise intensity, gut health, and immune system function, with a focus on gut microbiota dysbiosis. Researchers led by Hoseini et al. explored how different levels of physical activity impact gut epithelial cells and influence immune responses. The findings highlight the potential role of exercise in modulating gut health and immunity.

The study investigated the effects of varying intensities of physical exertion on the gut’s epithelial barrier and its interaction with immune mechanisms. Gut microbiota dysbiosis, which refers to an imbalance in microbial populations within the gastrointestinal tract, has been linked to several health issues. The research team analyzed how exercise could potentially counteract these imbalances by affecting cellular processes in the gut lining and altering immune system activity. The results provide insights into how physical activity may contribute to maintaining or improving overall gut health and immune function through specific biological pathways.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 26, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
LATEST
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
Janux Therapeutics Shares Halve Despite Positive Phase I Trial Results for Solid Tumor Therapy
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
2025-12-04
2025 Healthcare+ Expo Taiwan
Taipei, Taiwan
Scroll to Top